• Study to Identify Unknown Primary Cancer Using [18F]-AlF-FAPI-74 PET-CT for Patients with Carcinoma of Unknown Primary

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on Nivolumab and Ipilimumab for Patients with Untreated Unresectable or Metastatic Urothelial Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Denmark France Germany Greece Italy +5

  • Study Comparing Fluciclovine (18F) and Fluoroethyltyrosine F-18 PET Scans in Patients with New or Recurrent Brain Tumors and Brain Metastases

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on the Safety and Effects of INZ-701 for Infants with ENPP1 or ABCC6 Deficiency

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on the Effects of Dersimelagon Phosphate for Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria

    Not recruiting

    3 1
    Investigated Drugs:
    Bulgaria Czechia France Italy The Netherlands Poland +1

  • Study on Long-term Safety of TAK-881 (Human Normal Immunoglobulin, Hyaluronidase) for Patients with Primary Immunodeficiency Diseases

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Denmark Germany Greece The Netherlands Poland +2

  • Study of daily low-dose Temozolomide in patients with advanced neuroendocrine tumors (NETs) who are not eligible for standard treatments due to their health condition

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study on the Effects of Doravirine on Liver Health in People Living with HIV with Liver Steatosis or Fibrosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on Metformin for Reversing Accelerated Aging in People Aged 50+ Living with HIV

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on the Effects of Levosimendan for Patients with Cardiogenic Shock Being Weaned from ECMO

    Not recruiting

    2 1 1
    Investigated Drugs:
    Austria

powered by